biomodal Revenue and Competitors
Estimated Revenue & Valuation
- biomodal's estimated annual revenue is currently $18.3M per year.
- biomodal's estimated revenue per employee is $155,000
Employee Data
- biomodal has 118 Employees.
- biomodal grew their employee count by 23% last year.
biomodal's People
Name | Title | Email/Phone |
---|---|---|
1 | Lead Field Application Scientist | Reveal Email/Phone |
biomodal Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is biomodal?
biomodal is an omics based life-sciences technology and analytics company delivering products that bring the dynamism of our ever-changing biology into focus. Our duet multiomics solution enables more epigenetic information from a single, low input DNA library without complex, resource intensive bioinformatics or harsh chemical treatment. Our single-base-resolution, phased sequencing approach unlocks the combinatorial power of genetic and epigenetic information in one workflow, elucidating greater biological insight within the fields of cancer, neurodegenerative disease, and ageing.
keywords:N/AN/A
Total Funding
118
Number of Employees
$18.3M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 118 | 24% | $16.7M |
#2 | $38.1M | 118 | 7% | N/A |
#3 | $18.3M | 118 | -3% | $265M |
#4 | $23.7M | 118 | 42% | $25M |
#5 | $24.3M | 119 | 5% | N/A |